Association of G1057D variant of insulin receptor substrate-2 with endometriosis

Fertility and Sterility

Volumn 94, Issue 5, 2010, Pages 1622-1626

  Çayan, Filiz ^a   Ertun, Devrim ^a   Aras Ateş, Nurcan ^a   Ayaz, Lokman ^a   Akbay, Esen ^a   Karakaş, Sevim ^a   Çoban, Özgür ^a   Dilek, Saffet ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Endometriosis; IRS2 G1057D polymorphism; stage of the disease

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 2; INSULIN RECEPTOR SUBSTRATE;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; IRS2 GENE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; SEVERITY OF ILLNESS INDEX; UTERUS DISEASE;

ADULT; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UTERINE DISEASES;

EID: 77957197686     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.09.023     Document Type: Article

References (30)

1. D.K. Panidis, and I.M. Matalliotakis Subfertility associated with minimal to mild endometriosis. Main mechanisms J Reprod Med 43 1998 1034 1042
2. E. Seli, and A. Arici Endometriosis: interaction of immune and endocrine systems Semin Reprod Med 21 2003 135 144
3. M. Ulukus, H. Cakmak, and A. Arici The role of endometrium in endometriosis J Soc Gynecol Investig 13 2006 467 476
4. M.F. White Regulating insulin signaling and beta-cell function through IRS proteins Can J Physiol Pharmacol 84 2006 725 737
5. M.F. White The insulin signalling system and the IRS proteins Diabetologia 40 Suppl. 2 1997 S2 17
6. M.S. Burfoot, N.C. Rogers, D. Watling, J.M. Smith, S. Pons, and G. Paonessaw Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons J Biol Chem 272 1997 24183 24190
7. G. Sesti, M. Federici, M.L. Hribal, D. Lauro, P. Sbraccia, and R. Lauro Defects of the insulin receptor substrate (IRS) system in human metabolic disorders FASEB J 15 2001 2099 2111
8. J.G. Jackson, X. Zhang, T. Yoneda, and D. Yee Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines Oncogene 20 2001 7318 7325
9. X. Cui, H.J. Kim, I. Kuiatse, H. Kim, P.H. Brown, and A.V. Lee Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration Cancer Res 66 2006 5304 5313
10. C.D. Hoang, X. Zhang, P.D. Scott, T.J. Guillaume, M.A. Maddaus, and D. Yee Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes Cancer Res 64 2004 7479 7485
11. B. Kim, C.M. van Golen, and E.L. Feldman Insulin-like growth factor-I signaling in human neuroblastoma cells Oncogene 23 2004 130 141
12. W. He, A. Craparo, Y. Zhu, T.J. O'Neill, L.M. Wang, and J.H. Pierce Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2 J Biol Chem 271 1996 11641 11645
13. L. Quinones, D. Lucas, J. Godoy, D. Cáceres, F. Berthou, and N. Varela CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people Cancer Lett 174 2001 35 44
14. American Fertility Society Revised American Fertility classification of endometriosis: 1985 Fertil Steril 43 1985 351 352
15. D.A. Arvanitis, G.E. Koumantakis, A.G. Goumenou, I.M. Matalliotakis, E.E. Koumantakis, and D.A. Spandidos CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis Fertil Steril 79 2003 702 709
16. P. Mhawech, K. Kinkel, G. Vlastos, and M.F. Pelte Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study Int J Gynecol Pathol 21 2002 401 406
17. I.M. Matalliotakis, H. Cakmak, N. Mahutte, A.G. Goumenou, G. Koumantakis, and A. Arici The familial risk of breast cancer in women with endometriosis from Yale series Surg Oncol 17 2008 289 293
18. E.J. Thomas, and I.G. Campbell Evidence that endometriosis behaves in a malignant manner Gynecol Obstet Invest 50 2000 2 10
19. E.M. Rutanen Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery Hum Reprod 15 2000 173 181
20. J.M. Gross, and D. Yee The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: biology and therapeutic relevance Cancer Metastasis Rev 22 2003 327 336
21. C. Ganeff, G. Chatel, C. Munaut, F. Frankenne, J.M. Foidart, and R. Winkler The IGF system in in-vitro human decidualization Mol Hum Reprod 15 2009 27 38
22. L.C. Giudice, B.A. Dsupin, S.E. Gargosky, R.G. Rosenfeld, and J.C. Irwin The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis J Clin Endocrinol Metab 79 1994 1284 1293
23. J.A. Johnston, L.M. Wang, E.P. Hanson, X.J. Sun, M.F. White, and S.A. Oakes Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases J Biol Chem 270 1995 28527 28530
24. L.C. Platanias, S. Uddin, A. Yetter, X.J. Sun, and M.F. White The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2 J Biol Chem 271 1996 278 282
25. T. Yamauchi, Y. Kaburagi, K. Ueki, Y. Tsuji, G.R. Stark, and I.M. Kerr Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase J Biol Chem 273 1998 15719 15726
26. M. Neid, K. Datta, S. Stephan, I. Khanna, S. Pal, and L. Shaw Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells J Biol Chem 279 2004 3941 3948
27. D.R. Clemmons, and L.A. Maile Minireview: integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling Endocrinology 144 2003 1664 1670
28. J.A. Nagle, Z. Ma, M.A. Byrne, M.F. White, and L.M. Shaw Involvement of insulin receptor substrate 2 in mammary tumor metastasis Mol Cell Biol 24 2004 9726 9735
29. B. Kim, and E.L. Feldman Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis Apoptosis 14 2009 665 673
30. M. Boissan, E. Beurel, D. Wendum, C. Rey, Y. Lécluse, and C. Housset Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma Am J Pathol 167 2005 869 877